The Disposition of Bioactive Compounds from Fruit Waste, Their Extraction, and Analysis Using Novel Technologies: A Review DOI Open Access
Anwar Ali,

Sakhawat Riaz,

Aysha Sameen

et al.

Processes, Journal Year: 2022, Volume and Issue: 10(10), P. 2014 - 2014

Published: Oct. 5, 2022

Fruit waste contains several bioactive components such as polyphenols, polysaccharides, and numerous other phytochemicals, including pigments. Furthermore, new financial opportunities are created by using fruit ‘leftovers’ a basis for bioactivities that may serve foods or food ingredients, strengthening the circular economy’s properties. From technical standpoint, organic phenolic substances have become more appealing to industry, in addition their application nutritional supplements functional meals. Several extraction methods recovering compounds from already been published, most of which involve different solvents. However, there is growing demand eco-friendly sustainable techniques result phenolic-rich extracts with little ecological impact. Utilizing these advanced green will reduce global crisis caused management. Using modern techniques, residue degraded sub-zero scales, yielding bio-based commodities elements. This review highlights favorable creative separating materials residue. Extraction based on environmentally friendly technologies bioreactors, enzyme-assisted extraction, ultrasound-assisted combination specifically covered.

Language: Английский

Pathophysiology of Type 2 Diabetes Mellitus DOI Open Access

Unai Galicia-García,

Asier Benito‐Vicente,

Shifa Jebari

et al.

International Journal of Molecular Sciences, Journal Year: 2020, Volume and Issue: 21(17), P. 6275 - 6275

Published: Aug. 30, 2020

Type 2 Diabetes Mellitus (T2DM), one of the most common metabolic disorders, is caused by a combination two primary factors: defective insulin secretion pancreatic β-cells and inability insulin-sensitive tissues to respond appropriately insulin. Because release activity are essential processes for glucose homeostasis, molecular mechanisms involved in synthesis insulin, as well its detection tightly regulated. Defects any these can lead imbalance responsible development disease. This review analyzes key aspects T2DM, pathways implicated metabolism leading T2DM resistance. For that purpose, we summarize data gathered up until now, focusing especially on synthesis, release, sensing downstream effects individual organs. The also covers pathological conditions perpetuating such nutritional factors, physical activity, gut dysbiosis memory. Additionally, because associated with accelerated atherosclerosis development, here some link resistance (IR) cardiovascular risk important complications T2DM.

Language: Английский

Citations

2143

Oxidative Stress in Human Pathology and Aging: Molecular Mechanisms and Perspectives DOI Creative Commons

Younis Ahmad Hajam,

Raksha Rani,

Shahid Yousuf Ganie

et al.

Cells, Journal Year: 2022, Volume and Issue: 11(3), P. 552 - 552

Published: Feb. 5, 2022

Reactive oxygen and nitrogen species (RONS) are generated through various endogenous exogenous processes; however, they neutralized by enzymatic non-enzymatic antioxidants. An imbalance between the generation neutralization of oxidants results in progression to oxidative stress (OS), which turn gives rise diseases, disorders aging. The characteristics aging include progressive loss function tissues organs. theory explains that age-related functional losses due accumulation reactive (ROS), their subsequent damages tissue deformities. Moreover, diseases caused OS cardiovascular [CVDs], chronic obstructive pulmonary disease, kidney neurodegenerative cancer. OS, induced ROS, is different antioxidants prevents cells, organs from damage. However, prolonged decreases content antioxidant status cells reducing activities reductants antioxidative enzymes pathological conditions. Therefore, aim present review discuss mechanism ROS-induced signaling age-associated complications mediated toxic manifestations order devise effective preventive curative natural therapeutic remedies.

Language: Английский

Citations

528

Potential Adverse Effects of Resveratrol: A Literature Review DOI Open Access
Abdullah Shaito, Anna Maria Posadino,

Nadin Younes

et al.

International Journal of Molecular Sciences, Journal Year: 2020, Volume and Issue: 21(6), P. 2084 - 2084

Published: March 18, 2020

Due to its health benefits, resveratrol (RE) is one of the most researched natural polyphenols. Resveratrol’s benefits were first highlighted in early 1990s French paradox study, which opened extensive research activity into this compound. Ever since, several pharmacological activities including antioxidant, anti-aging, anti-inflammatory, anti-cancerous, anti-diabetic, cardioprotective, and neuroprotective properties, attributed RE. However, results from available human clinical trials controversial concerning protective effects RE against diseases their sequelae. The reason for these conflicting findings varied but differences characteristics enrolled patients, doses used, duration supplementation proposed, at least part, as possible causes. In particular, optimal dosage capable maximizing without raising toxicity issues remains an area research. context, while there a consistent body literature on diseases, are relatively few reports investigating toxicity. Indeed, adverse reported following consumption RE; therefore, future studies long-term effects, well vivo humans needed. Furthermore, data interactions when combined with other therapies still lacking, related absorption bioavailability body. review, we collect summarize about side effects. process, analyze vitro that have addressed stilbenoid. These suggest has unexplored side. Finally, discuss new delivery methods being employed overcome low

Language: Английский

Citations

504

PGC-1α, Inflammation, and Oxidative Stress: An Integrative View in Metabolism DOI Creative Commons
Sergio Rius‐Pérez, Isabel Torres-Cuevas, Iván Millán

et al.

Oxidative Medicine and Cellular Longevity, Journal Year: 2020, Volume and Issue: 2020, P. 1 - 20

Published: March 9, 2020

Peroxisome proliferator-activated receptor- γ coactivator (PGC)-1 α is a transcriptional described as master regulator of mitochondrial biogenesis and function, including oxidative phosphorylation reactive oxygen species detoxification. PGC-1 highly expressed in tissues with high energy demands, it clearly associated the pathogenesis metabolic syndrome its principal complications obesity, type 2 diabetes mellitus, cardiovascular disease, hepatic steatosis. We herein review molecular pathways regulated by , which connect stress metabolism inflammatory response syndrome. regulates expression antioxidant genes, manganese superoxide dismutase, catalase, peroxiredoxin 3 5, uncoupling protein 2, thioredoxin reductase thus prevents injury dysfunction. Dysregulation alters redox homeostasis cells exacerbates response, commonly accompanied disturbances. During inflammation, low levels downregulate gene expression, induce stress, promote nuclear factor kappa B activation. In syndrome, characterized chronic grade dysregulation modifies properties altering function promoting accumulation. conclusion, acts an essential node connecting regulation, control, pathways, interesting therapeutic target that may have significant benefits for number diseases.

Language: Английский

Citations

471

Diet and depression: exploring the biological mechanisms of action DOI
Wolfgang Marx, Melissa M. Lane, Meghan Hockey

et al.

Molecular Psychiatry, Journal Year: 2020, Volume and Issue: 26(1), P. 134 - 150

Published: Nov. 3, 2020

Language: Английский

Citations

464

Mitochondrial dysfunction in metabolic syndrome DOI
Pankaj Prasun

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, Journal Year: 2020, Volume and Issue: 1866(10), P. 165838 - 165838

Published: May 16, 2020

Language: Английский

Citations

259

Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury DOI Creative Commons
Wiramon Rungratanawanich, Ying Qu, Xin Wang

et al.

Experimental & Molecular Medicine, Journal Year: 2021, Volume and Issue: 53(2), P. 168 - 188

Published: Feb. 1, 2021

Abstract Advanced glycation end products (AGEs) are potentially harmful and heterogeneous molecules derived from nonenzymatic glycation. The pathological implications of AGEs ascribed to their ability promote oxidative stress, inflammation, apoptosis. Recent studies in basic translational research have revealed the contributing roles development progression various aging-related conditions, such as diabetes, cardiovascular complications, gut microbiome-associated illnesses, liver or neurodegenerative diseases, cancer. Excessive chronic and/or acute binge consumption alcohol (ethanol), a widely consumed addictive substance, is known cause more than 200 including use disorder (addiction), alcoholic disease, brain damage. However, despite considerable amount this area, underlying molecular mechanisms by which abuse causes cellular toxicity organ damage remain be further characterized. In review, we first briefly describe properties AGEs: formation, accumulation, receptor interactions. We then focus on causative functions that impact diseases. also highlight biological connection AGE–alcohol–adduct formations alcohol-mediated tissue injury. Finally, potential opportunities for treatment AGE- alcohol-related adduct-associated disorders according mechanistic insights presented.

Language: Английский

Citations

249

Chronic tissue inflammation and metabolic disease DOI Open Access
Yun Sok Lee, Jerrold M. Olefsky

Genes & Development, Journal Year: 2021, Volume and Issue: 35(5-6), P. 307 - 328

Published: March 1, 2021

Obesity is the most common cause of insulin resistance, and current obesity epidemic driving a parallel rise in incidence T2DM. It now widely recognized that chronic, subacute tissue inflammation major etiologic component pathogenesis resistance metabolic dysfunction obesity. Here, we summarize recent advances our understanding immunometabolism. We discuss characteristics chronic tissues how triggers these events, including focus on role adipose hypoxia macrophage-derived exosomes. Last, also review potential new therapeutic strategies based immunomodulation.

Language: Английский

Citations

201

A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan DOI Creative Commons
Ibrahim Mohammed, Morley D. Hollenberg, Hong Ding

et al.

Frontiers in Endocrinology, Journal Year: 2021, Volume and Issue: 12

Published: Aug. 5, 2021

The numerous beneficial health outcomes associated with the use of metformin to treat patients type 2 diabetes (T2DM), together data from pre-clinical studies in animals including nematode, C. elegans, and mice have prompted investigations into whether has therapeutic utility as an anti-aging drug that may also extend lifespan. Indeed, clinical trials, MILES (Metformin In Longevity Study) TAME (Targeting Aging Metformin), been designed assess potential benefits drug. Preliminary analysis results indicate induce transcriptional changes; however it remains controversial is protective those subjects free disease. Furthermore, despite for over 60 years anti-diabetic drug, cellular mechanisms by which exerts either its actions remain unclear. this review, we critically evaluated literature investigated effects on aging, healthspan lifespan humans well other species. preparing particular attention placed strength reproducibility quality study protocols respect pharmacokinetic pharmacodynamic properties metformin. We conclude support benefits, evidence increases controversial. However, via ability reduce early mortality various diseases, diabetes, cardiovascular disease, cognitive decline cancer, can improve thereby extending period life spent good health. Based available aging are primarily indirect metabolism result anti-hyperglycemic action, enhancing insulin sensitivity, reduction oxidative stress endothelium vascular function.

Language: Английский

Citations

195

Food as medicine: targeting the uraemic phenotype in chronic kidney disease DOI
Denise Mafra, Natália A. Borges, Bengt Lindholm

et al.

Nature Reviews Nephrology, Journal Year: 2020, Volume and Issue: 17(3), P. 153 - 171

Published: Sept. 22, 2020

Language: Английский

Citations

186